KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $143,000 | +19.2% | 23,263 | +13.2% | 0.00% | – |
Q4 2016 | $120,000 | -90.1% | 20,545 | -91.0% | 0.00% | – |
Q3 2016 | $1,213,000 | +840.3% | 228,490 | +1074.5% | 0.00% | – |
Q2 2016 | $129,000 | -96.1% | 19,454 | -97.9% | 0.00% | -100.0% |
Q3 2015 | $3,285,000 | -78.2% | 933,215 | -38.2% | 0.00% | -83.3% |
Q2 2015 | $15,067,000 | +24.8% | 1,509,804 | +59.2% | 0.01% | +20.0% |
Q1 2015 | $12,071,000 | -10.0% | 948,182 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $13,416,000 | +2.9% | 948,182 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $13,038,000 | -10.6% | 948,182 | 0.0% | 0.01% | -16.7% |
Q2 2014 | $14,583,000 | -48.3% | 948,182 | -42.7% | 0.01% | -45.5% |
Q1 2014 | $28,192,000 | +53.3% | 1,654,443 | +16.5% | 0.01% | +57.1% |
Q4 2013 | $18,389,000 | +56.4% | 1,419,947 | +21.8% | 0.01% | +40.0% |
Q3 2013 | $11,759,000 | +79.8% | 1,165,412 | +33.1% | 0.01% | +66.7% |
Q2 2013 | $6,539,000 | – | 875,361 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |